Sergiusz Jozwiak Selected Research

Pyridoxine (Pyridoxin)

12/2008

Pyridoxine-dependent seizures caused by alpha amino adipic semialdehyde dehydrogenase deficiency: the first polish case with confirmed biochemical and molecular pathology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sergiusz Jozwiak Research Topics

Disease

63	Tuberous Sclerosis (Bourneville's Disease) 11/2023 - 10/2002
25	Astrocytoma (Pilocytic Astrocytoma) 01/2023 - 12/2004
16	Epilepsy (Aura) 11/2023 - 03/2016
14	Neoplasms (Cancer) 01/2023 - 03/2006
11	Inborn Genetic Diseases (Disease, Hereditary) 07/2022 - 01/2013
10	Seizures (Absence Seizure) 11/2023 - 12/2008
10	Angiomyolipoma 01/2020 - 10/2002
6	Brain Neoplasms (Brain Tumor) 01/2023 - 04/2010
4	Autism Spectrum Disorder 07/2022 - 06/2019
4	Intellectual Disability (Idiocy) 07/2022 - 03/2016
3	Brain Diseases (Brain Disorder) 11/2023 - 03/2016
3	Angiofibroma 01/2023 - 07/2013
3	Hamartoma 01/2020 - 10/2002
3	Neurocutaneous Syndromes (Phakomatoses) 01/2020 - 02/2009
3	Autistic Disorder (Autism) 01/2020 - 01/2017
3	Carcinogenesis 01/2020 - 04/2010
2	Rare Diseases (Rare Disease) 01/2021 - 11/2014
2	Ganglioglioma 01/2021 - 06/2018
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 06/2018
2	Glioma (Gliomas) 01/2021 - 06/2018
2	Stomatitis 01/2021 - 01/2013
2	Infantile Spasms (West Syndrome) 01/2021 - 03/2019
2	Infections 01/2021 - 04/2015
2	Cognitive Dysfunction 10/2020 - 10/2010
2	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2019 - 01/2017
2	Rhabdomyoma 01/2017 - 07/2013
2	Renal Cell Carcinoma (Grawitz Tumor) 04/2015 - 07/2014
1	Spasm (Spasms) 11/2023
1	Drug Resistant Epilepsy 01/2022
1	Tuberculosis (Tuberculoses) 01/2022
1	Neurodevelopmental Disorders 10/2021
1	Bronchitis 01/2021
1	Diarrhea 01/2021
1	Neurologic Manifestations (Neurological Manifestations) 01/2021
1	Neutropenia 01/2021
1	Anemia 01/2021
1	Hyperglycemia 01/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Hydrocephalus (Hydrocephaly) 01/2020
1	Focal Cortical Dysplasia 01/2019
1	Temporal Lobe Epilepsy 01/2019
1	Febrile Seizures (Febrile Seizure) 01/2017
1	Inflammation (Inflammations) 01/2017
1	Sepsis (Septicemia) 04/2015
1	Glandular and Epithelial Neoplasms (Neoplasms, Glandular) 07/2014
1	Fever (Fevers) 01/2013
1	Neurodegeneration with brain iron accumulation (NBIA) 10/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2011
1	Disease Progression 10/2010
1	Multiple Sclerosis 10/2010
1	Brain Injuries (Brain Injury) 01/2010
1	Persistent Vegetative State (Vegetative State) 01/2010
1	Status Epilepticus (Complex Partial Status Epilepticus) 12/2008
1	Pyridoxine-dependent epilepsy 12/2008
1	Nervous System Diseases (Neurological Disorders) 02/2008

Drug/Important Bio-Agent (IBA)

57	trans-sodium crocetinate (crocetin)IBA 11/2023 - 10/2002
15	TOR Serine-Threonine KinasesIBA 01/2020 - 01/2007
14	Everolimus FDA Link 11/2023 - 01/2013
6	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2017
6	Vigabatrin FDA Link 11/2023 - 12/2019
5	Proteins (Proteins, Gene)FDA Link 10/2020 - 01/2005
4	Sirolimus (Rapamycin)FDA Link 11/2022 - 03/2006
4	Mechanistic Target of Rapamycin Complex 1IBA 10/2021 - 01/2017
4	Tuberous Sclerosis Complex 2 ProteinIBA 09/2016 - 01/2005
3	MTOR InhibitorsIBA 01/2023 - 11/2018
3	MicroRNAs (MicroRNA)IBA 07/2022 - 09/2016
3	Anticonvulsants (Antiepileptic Drugs)IBA 12/2019 - 04/2015
3	Tuberous Sclerosis Complex 1 ProteinIBA 09/2016 - 01/2005
2	SteroidsIBA 01/2022 - 01/2021
2	IronIBA 01/2017 - 10/2011
1	SandIBA 11/2023
1	CannabidiolIBA 11/2023
1	VaccinesIBA 01/2022
1	Cell Adhesion MoleculesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	gamma-Aminobutyric Acid (GABA)IBA 03/2019
1	Aminobutyrates (Aminobutyric Acid)IBA 03/2019
1	lipoarabinomannan (LAM)IBA 01/2019
1	Ion Channels (Ion Channel)IBA 01/2019
1	HMGB1 Protein (HMG1)IBA 01/2017
1	CytokinesIBA 01/2017
1	Glutamate-Cysteine LigaseIBA 07/2015
1	VimentinIBA 07/2014
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 07/2014
1	Carbonic Anhydrase IXIBA 07/2014
1	allysineIBA 12/2008
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 12/2008
1	Midazolam (Versed)FDA LinkGeneric 12/2008
1	Phenytoin (Dilantin)FDA LinkGeneric 12/2008
1	Phenobarbital (Luminal)FDA Link 12/2008
1	Oxidoreductases (Dehydrogenase)IBA 12/2008
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 01/2007
1	90-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 90 kDa)IBA 01/2007
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2007

Therapy/Procedure

11	Therapeutics 01/2023 - 03/2006
1	Duration of Therapy 01/2020
1	Induced Heart Arrest (Cardioplegia) 01/2010
1	Transplantation 01/2010